273 related articles for article (PubMed ID: 28174261)
1. Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development.
Acevedo-Calado M; James EA; Morran MP; Pietropaolo SL; Ouyang Q; Arribas-Layton D; Songini M; Liguori M; Casu A; Auchus RJ; Huang S; Yu L; Michels A; Gianani R; Pietropaolo M
Diabetes Care; 2017 Apr; 40(4):561-568. PubMed ID: 28174261
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR4-associated T and B cell responses to specific determinants on the IA-2 autoantigen in type 1 diabetes.
McLaughlin KA; Gulati K; Richardson CC; Morgan D; Bodansky HJ; Feltbower RG; Christie MR
J Immunol; 2014 Nov; 193(9):4448-56. PubMed ID: 25225671
[TBL] [Abstract][Full Text] [Related]
4. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
5. Relationships between major epitopes of the IA-2 autoantigen in Type 1 diabetes: Implications for determinant spreading.
McLaughlin KA; Richardson CC; Williams S; Bonifacio E; Morgan D; Feltbower RG; Powell M; Rees Smith B; Furmaniak J; Christie MR
Clin Immunol; 2015 Oct; 160(2):226-36. PubMed ID: 26071317
[TBL] [Abstract][Full Text] [Related]
6. Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes.
Morran MP; Casu A; Arena VC; Pietropaolo S; Zhang YJ; Satin LS; Nelson P; Omenn GS; Trucco M; Becker DJ; Pietropaolo M
Endocrinology; 2010 Jun; 151(6):2528-37. PubMed ID: 20382696
[TBL] [Abstract][Full Text] [Related]
7. Influence of HLA-DR and -DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes.
Richardson CC; McLaughlin KA; Morgan D; Feltbower RG; Christie MR
Diabetologia; 2016 Feb; 59(2):334-40. PubMed ID: 26564179
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes.
Mulukutla SN; Acevedo-Calado M; Hampe CS; Pietropaolo M; Balasubramanyam A
Diabetes Care; 2018 Dec; 41(12):2637-2640. PubMed ID: 30327357
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
[TBL] [Abstract][Full Text] [Related]
11. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes.
Weenink SM; Lo J; Stephenson CR; McKinney PA; Ananieva-Jordanova R; Rees Smith B; Furmaniak J; Tremble JM; Bodansky HJ; Christie MR
J Autoimmun; 2009 Sep; 33(2):147-54. PubMed ID: 19447008
[TBL] [Abstract][Full Text] [Related]
13. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs.
Kawasaki E; Yu L; Gianani R; Verge CF; Babu S; Bonifacio E; Eisenbarth GS
J Clin Endocrinol Metab; 1997 Feb; 82(2):375-80. PubMed ID: 9024221
[TBL] [Abstract][Full Text] [Related]
15. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens.
Bearzatto M; Naserke H; Piquer S; Koczwara K; Lampasona V; Williams A; Christie MR; Bingley PJ; Ziegler AG; Bonifacio E
J Immunol; 2002 Apr; 168(8):4202-8. PubMed ID: 11937581
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
17. T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus.
Dotta F; Dionisi S; Viglietta V; Tiberti C; Matteoli MC; Cervoni M; Bizzarri C; Marietti G; Testi M; Multari G; Lucentini L; Di Mario U
Eur J Endocrinol; 1999 Sep; 141(3):272-8. PubMed ID: 10474125
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS
Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177
[TBL] [Abstract][Full Text] [Related]
19. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
[TBL] [Abstract][Full Text] [Related]
20. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
